A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Abb Vie Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,137,571 shares of ABBV stock, worth $201 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,137,571
Previous 1,304,671 12.81%
Holding current value
$201 Million
Previous $224 Million 0.39%
% of portfolio
0.36%
Previous 0.39%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $27.4 Million - $33.3 Million
-167,100 Reduced 12.81%
1,137,571 $225 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $27.2 Million - $31.8 Million
175,677 Added 15.56%
1,304,671 $224 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $139 Million - $158 Million
-867,717 Reduced 43.46%
1,128,994 $206 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $87.9 Million - $99 Million
638,612 Added 47.02%
1,996,711 $309 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $9.48 Million - $11 Million
70,991 Added 5.52%
1,358,099 $202 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $128 Million - $159 Million
964,212 Added 298.61%
1,287,108 $173 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $2.3 Million - $2.65 Million
-15,900 Reduced 4.69%
322,896 $51.5 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $3.68 Million - $4.41 Million
-26,606 Reduced 7.28%
338,796 $54.8 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $132 Million - $152 Million
-985,578 Reduced 72.95%
365,402 $49 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $58.9 Million - $74.8 Million
427,677 Added 46.32%
1,350,980 $207 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $149 Million - $185 Million
-1,130,274 Reduced 55.04%
923,303 $150 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $1.86 Million - $2.35 Million
-17,317 Reduced 0.84%
2,053,577 $278 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $143 Million - $162 Million
1,340,970 Added 183.71%
2,070,894 $223 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $12.3 Million - $13.7 Million
-117,113 Reduced 13.83%
729,924 $82.2 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $534 Million - $587 Million
-5,215,538 Reduced 86.03%
847,037 $91.7 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $596 Million - $805 Million
-7,408,228 Reduced 54.99%
6,062,575 $650 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $477 Million - $560 Million
-5,551,066 Reduced 29.18%
13,470,803 $1.18 Billion
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $401 Million - $537 Million
5,466,020 Added 40.32%
19,021,869 $1.87 Billion
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $113 Million - $172 Million
1,759,105 Added 14.91%
13,555,849 $1.03 Billion
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $324 Million - $405 Million
4,490,046 Added 61.45%
11,796,744 $1.04 Billion
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $174 Million - $210 Million
2,768,156 Added 60.99%
7,306,698 $553 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $136 Million - $173 Million
2,064,486 Added 83.45%
4,538,542 $330 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $183 Million - $216 Million
2,374,556 Added 2386.49%
2,474,056 $199 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $7.75 Million - $9.55 Million
99,500 New
99,500 $9.17 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.